These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15331069)

  • 1. The potential role of genes in nonalcoholic fatty liver disease.
    Day CP
    Clin Liver Dis; 2004 Aug; 8(3):673-91, xi. PubMed ID: 15331069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic studies to identify hepatic fibrosis genes and SNPs in human populations.
    Day CP
    Methods Mol Med; 2005; 117():315-31. PubMed ID: 16118460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influences in nonalcoholic fatty liver disease.
    Merriman RB; Aouizerat BE; Bass NM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S30-3. PubMed ID: 16540764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.
    Wilfred de Alwis NM; Day CP
    Semin Liver Dis; 2007 Feb; 27(1):44-54. PubMed ID: 17295176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
    Tilg H; Moschen A
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Day CP
    Dig Dis; 2010; 28(1):255-60. PubMed ID: 20460920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
    Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
    Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.
    Day CP
    Liver Int; 2006 Nov; 26(9):1021-8. PubMed ID: 17032401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
    Choudhury J; Sanyal AJ
    Clin Liver Dis; 2004 Aug; 8(3):575-94, ix. PubMed ID: 15331065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease.
    Daly AK; Ballestri S; Carulli L; Loria P; Day CP
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):253-63. PubMed ID: 21476920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).
    Sazci A; Ergul E; Aygun C; Akpinar G; Senturk O; Hulagu S
    Cell Biochem Funct; 2008 Apr; 26(3):291-6. PubMed ID: 17563923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X; Li Z
    Chin J Dig Dis; 2006; 7(1):7-11. PubMed ID: 16412031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
    Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.